Literature DB >> 1599707

Antigenic heterogeneity of strains of Saccharomyces cerevisiae and Candida albicans recognised by serum antibodies from patients with Crohn's disease.

H McKenzie1, D Parratt, J Main, C R Pennington.   

Abstract

The antigenic heterogeneity of twelve strains of Saccharomyces cerevisiae and serovar A and B strains of Candida albicans was investigated by cross-absorption of serum antibodies from a patient with Crohn's disease. On the basis of common antibody absorption patterns, eleven of the yeast strains were divided into Group 1 (five S. cerevisiae), Group 2 (two C. albicans, one S. cerevisiae) and Group 3 (three S. cerevisiae). The remaining three S. cerevisiae strains (Group 4) showed unique absorption patterns. The antigenic relationship between S. cerevisiae and C. albicans was further studied by cross-absorption of sera from eight patients with Crohn's disease. This confirmed a limited degree of cross-reaction between most strains of S. cerevisiae and C. albicans, but C. albicans serovar B significantly absorbed antibodies to more S. cerevisiae strains than did C. albicans serovar A. The results demonstrate considerable antigenic heterogeneity of S. cerevisiae and suggest that the elevated serum antibody levels to S. cerevisiae found in Crohn's disease are directed against multiple antigens.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1599707     DOI: 10.1111/j.1574-6968.1992.tb04997.x

Source DB:  PubMed          Journal:  FEMS Microbiol Immunol        ISSN: 0920-8534


  7 in total

1.  Detection of Candida albicans by culture, serology and PCR in clinical specimens from patients with ulcerative colitis: re-evaluation of an old hypothesis with a new perspective.

Authors:  A Kalkanci; C Tuncer; B Degertekin; A Eren; S Kustimur; M N Ilhan; A Dursun
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.099

2.  Circulating antibodies to Saccharomyces cerevisiae (bakers'/brewers' yeast) in gastrointestinal disease.

Authors:  C J Darroch; R M Barnes; J Dawson
Journal:  J Clin Pathol       Date:  1999-01       Impact factor: 3.411

3.  Specific antibody response to oligomannosidic epitopes in Crohn's disease.

Authors:  B Sendid; J F Colombel; P M Jacquinot; C Faille; J Fruit; A Cortot; D Lucidarme; D Camus; D Poulain
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

Review 4.  Current understanding of fungal microflora in inflammatory bowel disease pathogenesis.

Authors:  David Underhill; Jonathan Braun
Journal:  Inflamm Bowel Dis       Date:  2008-08       Impact factor: 5.325

5.  Serum and salivary IgA antibody responses to Saccharomyces cerevisiae, Candida albicans and Streptococcus mutans in orofacial granulomatosis and Crohn's disease.

Authors:  N W Savage; K Barnard; P J Shirlaw; D Rahman; M Mistry; M P Escudier; J D Sanderson; S J Challacombe
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

6.  Characterization of oligosaccharides from an antigenic mannan of Saccharomyces cerevisiae.

Authors:  M Young; M J Davies; D Bailey; M J Gradwell; B Smestad-Paulsen; J K Wold; R M Barnes; E F Hounsell
Journal:  Glycoconj J       Date:  1998-08       Impact factor: 2.916

Review 7.  Serological markers of inflammatory bowel disease.

Authors:  Andrea Tesija Kuna
Journal:  Biochem Med (Zagreb)       Date:  2013       Impact factor: 2.313

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.